NATCO Pharma Limited (NSE:NATCOPHARM)
India · Delayed Price · Currency is INR 905.20
-0.45 (-0.05%)
At close: Dec 15, 2025
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 162.13 billion as of December 15, 2025. Its market cap has decreased by -33.21% in one year.
Market Cap
162.13B
Enterprise Value
132.74B
Revenue
43.90B
Ranking
n/a
PE Ratio
10.54
Stock Price
905.20
Market Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 162.13B, an increase of 37,658.40%. That is a compound annual growth rate of 24.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 162.21B | -34.72% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | 175.25B | 62.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.30T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 934.94B |
| Mankind Pharma | 899.42B |
| Aurobindo Pharma | 694.12B |
| Alkem Laboratories | 673.27B |